hCG and Testicular Function: LH Mimicry Research

Research Disclaimer: hCG is sold exclusively for in-vitro and laboratory research use. Not for unsupervised use. This content does not constitute medical advice.

Human chorionic gonadotropin (hCG) is a glycoprotein hormone produced by the syncytiotrophoblast during pregnancy, structurally homologous to LH (luteinizing hormone). Both hCG and LH share the same β-subunit binding region for the LH/CG receptor (LHCGR) on Leydig cells, but hCG has a ~10× longer half-life due to additional glycosylation, making it a superior research tool for sustained Leydig cell stimulation. In androgen research, hCG is the primary tool for maintaining intratesticular testosterone (ITT) during exogenous androgen administration and for directly rescuing Leydig cell function during HPTA suppression.

Table of Contents#

1. hCG vs. LH: Structural Differences and LHCGR Binding
2. LHCGR Signaling: Leydig Cell Steroidogenesis
3. Intratesticular Testosterone (ITT) and Its Research Importance
4. hCG in Androgen Suppression Models
5. HPTA Recovery: hCG Role
6. Pharmacokinetics
7. Research Protocols
8. Key References

hCG vs. LH: Structural Differences and LHCGR Binding#

Both hCG and LH are glycoprotein heterodimers:

LHCGR binding: Both bind to the leucine-rich repeat (LRR) domain of LHCGR with high affinity (Kd ~1 nM for LH, similar for hCG). hCG's additional glycosylation slows receptor dissociation → longer signal duration from a single exposure.

LHCGR Signaling: Leydig Cell Steroidogenesis#

hCG → LHCGR → Gs → adenylyl cyclase → cAMP → PKA:

Acute (minutes–hours):

• PKA → phosphorylates and activates StAR (steroidogenic acute regulatory protein)
• StAR facilitates cholesterol import from outer to inner mitochondrial membrane
• CYP11A1 (P450scc) converts cholesterol → pregnenolone
• CYP17A1 → DHEA → androstenedione → 17β-HSD → testosterone

Chronic (>24h continuous hCG):

• LHCGR downregulation (receptor internalization) → attenuated response
• Leydig cell StAR and CYP enzyme mRNA upregulation (gene expression)
• Leydig cell hypertrophy and potential hyperplasia with sustained hCG

Practical implications for research:

• Daily high-dose hCG → LHCGR desensitization → diminishing testosterone output over time
• Every-other-day or twice-weekly dosing → prevents excessive desensitization while maintaining adequate testosterone

Intratesticular Testosterone (ITT) and Its Research Importance#

Intratesticular testosterone (ITT) is the testosterone concentration within the testis itself:

• ITT is ~50–100× higher than serum testosterone (humans: ITT ~500–600 ng/mL vs. serum ~600 ng/dL)
• ITT is essential for spermatogenesis: Sertoli cells require extremely high local testosterone for FSH-driven spermatid maturation
• Serum testosterone is NOT a reliable proxy for ITT

How exogenous testosterone suppresses ITT:

1. Exogenous testosterone → serum T elevated
2. HPTA suppression → LH → 0
3. Leydig cells: no LH stimulation → dramatically reduced steroidogenesis
4. ITT falls to <5% of normal (despite normal/high serum T)
5. Spermatogenesis: fails (requires local ITT 500 ng/mL, not serum 600 ng/dL)

hCG replaces LH to maintain ITT:

• hCG (even small doses) → LHCGR → cAMP → Leydig cell steroidogenesis
• ITT maintained despite HPTA suppression from exogenous testosterone
• Spermatogenesis preserved

Research importance: Any androgen study where testicular function, spermatogenesis, or fertility is an endpoint MUST include an hCG group to distinguish primary testicular effects from HPTA-mediated effects.

hCG in Androgen Suppression Models#

ITT maintenance during testosterone administration#

Standard model:

• Castrated rats: no endogenous testosterone, no ITT (relevant for exogenous androgen PD studies)
• Intact rats + exogenous testosterone → HPTA suppression → low ITT → spermatogenesis fails
• Intact rats + testosterone + hCG → HPTA suppression but ITT maintained → spermatogenesis preserved

This allows study of: "what are the systemic effects of testosterone (AR, E2, bone, muscle) WITHOUT testicular function loss?"

Leydig cell atrophy model#

Goal: produce Leydig cell atrophy then study recovery

• Exogenous testosterone (8–12 weeks) → LH=0 → Leydig cell atrophy
• Cessation → measure time to Leydig cell recovery
• hCG treatment group: accelerates Leydig cell recovery (direct LHCGR stimulation)

HPTA Recovery: hCG Role#

In PCT (post-cycle therapy) research, hCG is used in the first phase:

Rationale:

1. After androgen cessation → HPTA still suppressed for days–weeks
2. Leydig cells: atrophied, less responsive to endogenous LH even as it starts recovering
3. hCG → directly stimulates atrophied Leydig cells → rebuilds steroidogenic capacity
4. Then SERM (tamoxifen/clomiphene) → stimulates pituitary LH → sustains recovery

Timing matters:

• hCG during androgen use (concurrent): maintains Leydig cell health, prevents atrophy
• hCG after cessation (transition): bridges the LH-recovery gap
• hCG must NOT be continued indefinitely → high doses → LHCGR desensitization → paradoxical suppression

Pharmacokinetics#

Activity units: hCG is measured in International Units (IU), not mg — potency standardized against reference preparations. Common preparations: 5,000 IU/vial, 10,000 IU/vial.

Research Protocols#

ITT maintenance during exogenous testosterone treatment (rats)#

Leydig cell recovery study#

Key References#

1. Coviello AD, et al. (2005). "Effects of graded doses of testosterone on erythropoiesis in healthy young and older men." Journal of Clinical Endocrinology and Metabolism, 90(11):6005–6010.

2. Bhasin S, et al. (2004). "Proof of concept: testosterone supplementation in older men." Journal of Clinical Endocrinology and Metabolism, 89(10):5225–5235.

3. Jarow JP, et al. (1996). "Intratesticular testosterone levels and determinants." Endocrinology, 137(1):107–113.

Research Use Only: hCG is sold exclusively for in-vitro research and laboratory use. Not for unsupervised use. JuicedPharma does not provide medical advice.

Published by JuicedPharma Research Team · September 2026 · Category: Research Protocols & Science